Avecho Biotechnology Limited (AVE.AX)
AUD 0.0
(0.0%)
AUD 0.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -3.43 Million AUD | -46.71% |
| 2022 | -2.34 Million AUD | 31.43% |
| 2021 | -3.41 Million AUD | -29.65% |
| 2020 | -2.63 Million AUD | -410.0% |
| 2019 | 849.95 Thousand AUD | 121.3% |
| 2018 | -3.99 Million AUD | 53.69% |
| 2017 | -8.61 Million AUD | 50.03% |
| 2016 | -17.24 Million AUD | 11.9% |
| 2015 | -19.57 Million AUD | -119.1% |
| 2014 | -8.93 Million AUD | 29.5% |
| 2013 | -12.67 Million AUD | -14.64% |
| 2012 | -11.05 Million AUD | -1099.55% |
| 2011 | 1.1 Million AUD | 109.81% |
| 2010 | -11.27 Million AUD | -32.63% |
| 2009 | -8.5 Million AUD | 90.68% |
| 2008 | -91.2 Million AUD | -931.28% |
| 2007 | -8.84 Million AUD | -44.39% |
| 2006 | -6.12 Million AUD | 16.36% |
| 2005 | -7.32 Million AUD | -132.6% |
| 2004 | -3.14 Million AUD | -18.28% |
| 2003 | -2.66 Million AUD | 38.8% |
| 2002 | -4.34 Million AUD | 18.94% |
| 2001 | -5.36 Million AUD | -356.98% |
| 2000 | -1.17 Million AUD | -333.13% |
| 1999 | 503.57 Thousand AUD | 113.04% |
| 1998 | -3.86 Million AUD | 82.2% |
| 1997 | -21.69 Million AUD | -600.68% |
| 1996 | -3.09 Million AUD | -117.57% |
| 1995 | 17.62 Million AUD | 5267.74% |
| 1994 | -341 Thousand AUD | -141.79% |
| 1993 | 816 Thousand AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -2.17 Million AUD | 0.0% |
| 2023 Q2 | -2.12 Million AUD | 0.0% |
| 2023 FY | -3.43 Million AUD | -46.71% |
| 2023 Q4 | -1.3 Million AUD | 0.0% |
| 2022 Q4 | -1.56 Million AUD | 0.0% |
| 2022 Q2 | -777.67 Thousand AUD | 0.0% |
| 2022 FY | -2.34 Million AUD | 31.43% |
| 2021 Q2 | -1.73 Million AUD | 0.0% |
| 2021 Q4 | -1.67 Million AUD | 0.0% |
| 2021 FY | -3.41 Million AUD | -29.65% |
| 2020 Q4 | -1.76 Million AUD | 0.0% |
| 2020 FY | -2.63 Million AUD | -410.0% |
| 2020 Q2 | -872.48 Thousand AUD | 0.0% |
| 2019 Q2 | 2.3 Million AUD | 0.0% |
| 2019 Q4 | -1.45 Million AUD | 0.0% |
| 2019 FY | 849.95 Thousand AUD | 121.3% |
| 2018 FY | -3.99 Million AUD | 53.69% |
| 2018 Q2 | -1.84 Million AUD | 0.0% |
| 2018 Q4 | -2.14 Million AUD | 0.0% |
| 2017 FY | -8.61 Million AUD | 50.03% |
| 2017 Q2 | -4.18 Million AUD | 0.0% |
| 2016 FY | -17.24 Million AUD | 11.9% |
| 2016 Q4 | -11.84 Million AUD | 0.0% |
| 2016 Q2 | -5.4 Million AUD | 0.0% |
| 2015 FY | -19.57 Million AUD | -119.1% |
| 2015 Q4 | -11.37 Million AUD | 0.0% |
| 2015 Q2 | -8.2 Million AUD | 0.0% |
| 2014 Q4 | -5.31 Million AUD | -137.99% |
| 2014 Q1 | -2.23 Million AUD | 0.0% |
| 2014 Q2 | -2.11 Million AUD | 5.18% |
| 2014 FY | -8.93 Million AUD | 29.5% |
| 2014 Q3 | -2.23 Million AUD | -5.47% |
| 2013 Q3 | -3.16 Million AUD | 47.82% |
| 2013 Q4 | -2.23 Million AUD | 29.5% |
| 2013 FY | -12.67 Million AUD | -14.64% |
| 2013 Q1 | -3.16 Million AUD | 0.0% |
| 2013 Q2 | -6.07 Million AUD | -91.65% |
| 2012 Q2 | -2.76 Million AUD | 0.0% |
| 2012 Q1 | -2.76 Million AUD | 0.0% |
| 2012 Q4 | -3.16 Million AUD | -14.64% |
| 2012 FY | -11.05 Million AUD | -1099.55% |
| 2012 Q3 | -2.76 Million AUD | 0.0% |
| 2011 Q4 | -2.76 Million AUD | -1099.55% |
| 2011 Q3 | 276.5 Thousand AUD | 0.0% |
| 2011 Q2 | 276.5 Thousand AUD | 0.0% |
| 2011 FY | 1.1 Million AUD | 109.81% |
| 2011 Q1 | 276.5 Thousand AUD | 0.0% |
| 2010 FY | -11.27 Million AUD | -32.63% |
| 2010 Q3 | -2.81 Million AUD | 0.0% |
| 2010 Q4 | 276.5 Thousand AUD | 109.81% |
| 2010 Q1 | -2.81 Million AUD | 0.0% |
| 2010 Q2 | -2.81 Million AUD | 0.0% |
| 2009 Q2 | -2.12 Million AUD | 0.0% |
| 2009 Q4 | -2.81 Million AUD | -32.63% |
| 2009 Q3 | -2.12 Million AUD | 0.0% |
| 2009 FY | -8.5 Million AUD | 90.68% |
| 2009 Q1 | -2.12 Million AUD | 0.0% |
| 2008 Q1 | -22.8 Million AUD | 0.0% |
| 2008 Q2 | -22.8 Million AUD | 0.0% |
| 2008 Q3 | -22.8 Million AUD | 0.0% |
| 2008 Q4 | -2.12 Million AUD | 90.68% |
| 2008 FY | -91.2 Million AUD | -931.28% |
| 2007 Q2 | -2.21 Million AUD | 0.0% |
| 2007 FY | -8.84 Million AUD | -44.39% |
| 2007 Q1 | -2.21 Million AUD | 0.0% |
| 2007 Q3 | -2.21 Million AUD | 0.0% |
| 2007 Q4 | -22.8 Million AUD | -931.28% |
| 2006 FY | -6.12 Million AUD | 16.36% |
| 2006 Q4 | -2.21 Million AUD | -44.39% |
| 2006 Q3 | -1.53 Million AUD | 0.0% |
| 2006 Q2 | -1.53 Million AUD | 0.0% |
| 2006 Q1 | -1.53 Million AUD | 0.0% |
| 2005 Q2 | -1.83 Million AUD | 0.0% |
| 2005 Q4 | -1.53 Million AUD | 16.36% |
| 2005 Q3 | -1.83 Million AUD | 0.0% |
| 2005 FY | -7.32 Million AUD | -132.6% |
| 2005 Q1 | -1.83 Million AUD | 0.0% |
| 2004 Q4 | -1.83 Million AUD | 0.0% |
| 2004 FY | -3.14 Million AUD | -18.28% |
| 2004 Q2 | - AUD | 0.0% |
| 2004 Q3 | - AUD | 0.0% |
| 2004 Q1 | - AUD | 0.0% |
| 2003 Q2 | - AUD | 0.0% |
| 2003 Q4 | - AUD | 0.0% |
| 2003 Q3 | - AUD | 0.0% |
| 2003 Q1 | - AUD | 0.0% |
| 2003 FY | -2.66 Million AUD | 38.8% |
| 2002 FY | -4.34 Million AUD | 18.94% |
| 2002 Q4 | - AUD | 0.0% |
| 2002 Q3 | - AUD | 0.0% |
| 2002 Q2 | - AUD | 0.0% |
| 2002 Q1 | - AUD | 0.0% |
| 2001 Q1 | - AUD | 0.0% |
| 2001 FY | -5.36 Million AUD | -356.98% |
| 2001 Q2 | - AUD | 0.0% |
| 2001 Q4 | - AUD | 0.0% |
| 2001 Q3 | - AUD | 0.0% |
| 2000 Q3 | - AUD | 0.0% |
| 2000 Q4 | - AUD | 0.0% |
| 2000 FY | -1.17 Million AUD | -333.13% |
| 2000 Q2 | - AUD | 0.0% |
| 2000 Q1 | - AUD | 0.0% |
| 1999 Q3 | - AUD | 0.0% |
| 1999 FY | 503.57 Thousand AUD | 113.04% |
| 1999 Q1 | - AUD | 0.0% |
| 1999 Q2 | - AUD | 0.0% |
| 1999 Q4 | - AUD | 0.0% |
| 1998 FY | -3.86 Million AUD | 82.2% |
| 1998 Q4 | - AUD | 0.0% |
| 1998 Q3 | - AUD | 0.0% |
| 1998 Q2 | - AUD | 0.0% |
| 1998 Q1 | - AUD | 0.0% |
| 1997 Q2 | - AUD | 0.0% |
| 1997 Q1 | - AUD | 0.0% |
| 1997 Q3 | - AUD | 0.0% |
| 1997 FY | -21.69 Million AUD | -600.68% |
| 1997 Q4 | - AUD | 0.0% |
| 1996 Q2 | - AUD | 0.0% |
| 1996 Q4 | - AUD | 0.0% |
| 1996 Q1 | - AUD | 0.0% |
| 1996 Q3 | - AUD | 0.0% |
| 1996 FY | -3.09 Million AUD | -117.57% |
| 1995 Q4 | - AUD | 0.0% |
| 1995 FY | 17.62 Million AUD | 5267.74% |
| 1995 Q1 | - AUD | 0.0% |
| 1995 Q2 | - AUD | 0.0% |
| 1995 Q3 | - AUD | 0.0% |
| 1994 Q3 | - AUD | 0.0% |
| 1994 FY | -341 Thousand AUD | -141.79% |
| 1994 Q1 | - AUD | 0.0% |
| 1994 Q4 | - AUD | 0.0% |
| 1994 Q2 | - AUD | 0.0% |
| 1993 FY | 816 Thousand AUD | 0.0% |
| 1993 Q2 | - AUD | 0.0% |
| 1993 Q4 | - AUD | 0.0% |
| 1993 Q1 | - AUD | 0.0% |
| 1993 Q3 | - AUD | 0.0% |
| 1992 Q4 | - AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 6.96 Million AUD | 149.344% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -136.801% |
| Zelira Therapeutics Limited | -36.56 Million AUD | 90.603% |
| Biome Australia Limited | -1.67 Million AUD | -105.757% |
| Patrys Limited | -3.53 Million AUD | 2.899% |
| Orthocell Limited | -7.18 Million AUD | 52.143% |
| Imugene Limited | -149.68 Million AUD | 97.704% |
| Noxopharm Limited | -3.57 Million AUD | 3.956% |
| PYC Therapeutics Limited | -37.72 Million AUD | 90.891% |
| Chimeric Therapeutics Limited | -12.52 Million AUD | 72.573% |
| Prescient Therapeutics Limited | -8.23 Million AUD | 58.284% |
| Proteomics International Laboratories Limited | -6.37 Million AUD | 46.103% |
| Cynata Therapeutics Limited | -9.74 Million AUD | 64.734% |
| CSL Limited | 2.64 Billion AUD | 100.13% |
| Arovella Therapeutics Limited | -8.74 Million AUD | 60.707% |
| Bio-Gene Technology Limited | -2.4 Million AUD | -42.644% |
| Clinuvel Pharmaceuticals Limited | 35.63 Million AUD | 109.643% |
| Starpharma Holdings Limited | -8.16 Million AUD | 57.911% |
| Nanollose Limited | -1.15 Million AUD | -197.138% |
| Memphasys Limited | -4.44 Million AUD | 22.635% |
| Invex Therapeutics Ltd | -1.64 Million AUD | -109.316% |
| NeuroScientific Biopharmaceuticals Limited | 324.21 Thousand AUD | 1159.98% |
| Amplia Therapeutics Limited | -4.5 Million AUD | 23.691% |
| Botanix Pharmaceuticals Limited | -13.86 Million AUD | 75.223% |
| Island Pharmaceuticals Limited | -2.86 Million AUD | -19.978% |
| Race Oncology Limited | -13.81 Million AUD | 75.132% |
| Nyrada Inc. | -1.38 Million AUD | -147.908% |
| Telix Pharmaceuticals Limited | 5.21 Million AUD | 165.948% |
| Dimerix Limited | -17.07 Million AUD | 79.874% |
| PharmAust Limited | -9.03 Million AUD | 61.953% |
| Immutep Limited | -39.89 Million AUD | 91.386% |
| Clarity Pharmaceuticals Ltd | -42.32 Million AUD | 91.88% |
| Alterity Therapeutics Limited | -19.12 Million AUD | 82.03% |
| BTC Health Limited | 1.05 Million AUD | 425.652% |
| Acrux Limited | -5.8 Million AUD | 40.749% |
| Neuren Pharmaceuticals Limited | 157.08 Million AUD | 102.188% |
| Biotron Limited | -3.43 Million AUD | -0.001% |
| Tissue Repair Ltd | -4.13 Million AUD | 16.953% |
| AdAlta Limited | -5.38 Million AUD | 36.138% |
| Radiopharm Theranostics Limited | -47.94 Million AUD | 92.833% |
| Hexima Limited | -933.87 Thousand AUD | -267.99% |
| AnteoTech Limited | -8.88 Million AUD | 61.302% |
| Paradigm Biopharmaceuticals Limited | -58.65 Million AUD | 94.141% |
| Recce Pharmaceuticals Ltd | -17.66 Million AUD | 80.542% |
| Actinogen Medical Limited | -13.04 Million AUD | 73.655% |
| Immuron Limited | -6.93 Million AUD | 50.46% |
| Argenica Therapeutics Limited | -5.47 Million AUD | 37.283% |